Repeat Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Using Open and Closed Abdomen Techniques for Colorectal Peritoneal Metastases and Peritoneal Pseudomyxoma Recurrences: Results from Six French Expert Centers.

Date publication

novembre 2024

Journal

Annals of surgical oncology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr MARCHAL Frédéric

Tous les auteurs :
Tidadini F, Arvieux C, Glehen O, Sourrouille I, Marchal F, Abba J, Malgras B, Quesada JL, Pocard M, Ezanno AC

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/39496899

Résumé

Standard treatment for resectable peritoneal metastases (PM) combines cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC); however, the rate of recurrence remains high and repeat CRS/HIPEC may be considered in well-selected patients. We describe our postoperative and oncological outcomes.

Mots clés

Colorectal peritoneal metastases, Cytoreduction surgery (CRS), Hyperthermic intraperitoneal chemotherapy (HIPEC), Oncological outcomes, Peritoneal pseudomyxoma, Repeat CRS/HIPEC

Référence

Ann Surg Oncol. 2024 11 4;: